Sign in
Active, not recruitingNo phase

Microwave Ablation of Uterine Fibroids

Key facts

Who runs it
Turku University Hospital
Where
Finland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
100 people, planned
Started
1 May 2026
Expected to end
Dec 2034
Type of study
Observational
Treatments tested
  • microwave ablation
Record updated
21 August 2026

Who can take part

Age
18 years to 56 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • symptomatic fibroids
  • premenopausal status
  • acceptable risks for general anestesia or sedation
  • willing to undergo mwa treatment and participate in the study

Who cannot take part

  • bleeding disorder with increased risk of bleeding
  • postmenopausal status

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This prospective observational study aims to evaluate the effectiveness and acceptability of percutaneous or vaginal ultrasound guided microwave ablation for the treatment or symptomatic uterine fibroids. We will include 100 women.

The group in the trial

  • patients with symptomatic uterine fibroids

    Patients with symptomatic uterine fibroids, who will undergo microwave ablation of fibroids as a clinical treatment are recruited in this study.

    Treatment: microwave ablation

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Prospective Observational Study of Microwave Ablation of Uterine Fibroids (MyoMwa)
Record updated
21 August 2026